
Tian Zhang/utswmed.org
Jun 28, 2025, 23:19
Tian Zhang: Translational Research on Immunotherapy Nanoparticles Published in Molecular Cancer
Tian Zhang, Associate Director of Clinical Research at the Simmons Comprehensive Cancer Center, shared a post on X:
“Last week Dr. Andy Wang and I published 1st of our translational research in Molecular Cancer, developing a multifunctional immunotherapy nanoparticle (MINP) to treat kidney cancer. Thanks to Kinman Au and Siqing Li, 2 of our postdocs from UTSW Simmons Cancer Center who did the work.
Premised on the future of immunotherapy to engage both innate and adaptive immune systems, this MINP binds CA9 on RCC cells and delivers anti-4-1BB and anti-CD27 Abs. Both a4-1BB and aCD27 Abs are potent immune agonists activating both adaptive and innate immune response.
Because each nanoparticle is engineered with dozens of each antibody, this nanoformulation facilitates a “clustering effect”, which is critical for maximum signaling effects of 4-1BB and CD27 pathways.
After making these MINPs, our team showed these can activate both T-cells and NK cells in vitro – both adaptive and innate immune activation.
This MINP (aCA9, a4-1BB and aCD27) is highly effective against RCCs that overexpresses CA9, here with a series of well controlled NP studies showing best effect with the MINP in a xenograft model of RAG/hCA-9 cells.
Importantly, this novel MINP can overcome decreases in adaptive immunity attributed to aging in this #RCC model. In humanized mice with PBMCs from young donors, MINPs inhibit tumor growth, with 2 CRs — compared to mice with PBMCs from older donors having only PRs and no CRs.
Supported by David Lee KCRP Idea Development Award. We are grateful for the funding and the chance to make a difference for our patients with kidney cancer.”
Title: Biologically targeted dual adaptive and innate nano-Immunotherapy for clear cell renal cell carcinoma treatment
Authors: Kin Man Au, Siqing Li, Tian Zhang, Andrew Z. Wang
Read the Full Article.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 29, 2025, 09:16
Jun 29, 2025, 09:08
Jun 29, 2025, 09:07